Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257712 · ClinicalTrials.gov registry record · Phase 2
SMART: Somatotrophics, Memory, and Aging Research Trial
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 151
- Enrollment target
NCT00257712 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 151 participants.
The verdict
NCT00257712, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 151 participants
- Enrollment target
Study Summary
The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).
Interventions
- DRUG TH9507 human growth hormone releasing hormone (GHRH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2006-02 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257712
The ClinicalTrials.gov registry entry for NCT00257712 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TH9507 human growth hormone releasing hormone (GHRH) is the first listed.
NCT00257712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257712 about?
NCT00257712 is a clinical study titled "SMART: Somatotrophics, Memory, and Aging Research Trial". The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormon...
What is the current status of trial NCT00257712?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 151 participants. The study started on 2006-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00257712?
The interventions under investigation include: TH9507 human growth hormone releasing hormone (GHRH) (DRUG).
Who is sponsoring clinical trial NCT00257712?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.